Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?
Descripción del Articulo
Cerebrovascular disorders remain the leading cause of neurological morbidity and mortality in the world, representing one of the pathological entities responsible for the greatest burden of disease worldwide. Carotid atherosclerosis or stenosis is a potential risk factor for ischemic stroke. The ide...
| Autores: | , , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2023 |
| Institución: | Universidad de San Martín de Porres |
| Repositorio: | Horizonte médico |
| Lenguaje: | español inglés |
| OAI Identifier: | oai:horizontemedico.usmp.edu.pe:article/2245 |
| Enlace del recurso: | https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245 |
| Nivel de acceso: | acceso abierto |
| Materia: | stroke risk carotid artery diseases surgical procedures operative therapeutics accidente cerebrovascular riesgo enfermedades de las arterias carótidas procedimientos quirúrgicos operativos terapéutica |
| id |
REVHM_a95497873d7427e3fc07cd1808b3bde6 |
|---|---|
| oai_identifier_str |
oai:horizontemedico.usmp.edu.pe:article/2245 |
| network_acronym_str |
REVHM |
| network_name_str |
Horizonte médico |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically? Riesgo de accidente cerebrovascular en pacientes con aterosclerosis carotídea asintomática: ¿se debe tratar médicamente o quirúrgicamente? |
| title |
Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically? |
| spellingShingle |
Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically? Moreno Muñoz, Roberth Nixon stroke risk carotid artery diseases surgical procedures operative therapeutics accidente cerebrovascular riesgo enfermedades de las arterias carótidas procedimientos quirúrgicos operativos terapéutica |
| title_short |
Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically? |
| title_full |
Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically? |
| title_fullStr |
Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically? |
| title_full_unstemmed |
Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically? |
| title_sort |
Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically? |
| dc.creator.none.fl_str_mv |
Moreno Muñoz, Roberth Nixon Vergara Trujillo, Richard Adrián Guevara Lizarazo, German Andrés Brett Cano, Patrick Junior León Cuervo, Dalila Andrea Puerta Lidueñas, Adriana Marcela Sarmiento Figueroa, Mariana Ortega Sierra, Michael |
| author |
Moreno Muñoz, Roberth Nixon |
| author_facet |
Moreno Muñoz, Roberth Nixon Vergara Trujillo, Richard Adrián Guevara Lizarazo, German Andrés Brett Cano, Patrick Junior León Cuervo, Dalila Andrea Puerta Lidueñas, Adriana Marcela Sarmiento Figueroa, Mariana Ortega Sierra, Michael |
| author_role |
author |
| author2 |
Vergara Trujillo, Richard Adrián Guevara Lizarazo, German Andrés Brett Cano, Patrick Junior León Cuervo, Dalila Andrea Puerta Lidueñas, Adriana Marcela Sarmiento Figueroa, Mariana Ortega Sierra, Michael |
| author2_role |
author author author author author author author |
| dc.subject.none.fl_str_mv |
stroke risk carotid artery diseases surgical procedures operative therapeutics accidente cerebrovascular riesgo enfermedades de las arterias carótidas procedimientos quirúrgicos operativos terapéutica |
| topic |
stroke risk carotid artery diseases surgical procedures operative therapeutics accidente cerebrovascular riesgo enfermedades de las arterias carótidas procedimientos quirúrgicos operativos terapéutica |
| description |
Cerebrovascular disorders remain the leading cause of neurological morbidity and mortality in the world, representing one of the pathological entities responsible for the greatest burden of disease worldwide. Carotid atherosclerosis or stenosis is a potential risk factor for ischemic stroke. The identification and strict follow-up of this condition are essential in the secondary prevention of complications through primary care and the specialized treatment of cardiometabolicrisk. However, depending on this risk and/or presence of symptoms, definitive treatment is necessary. Currently, there is controversy as to whether asymptomatic carotid stenosis is better to be treated medically or surgically. Consideringthe significance of such entity, this review aims to analyze recent evidence on the risk of ischemic stroke in the case of asymptomatic carotid atherosclerosis among adults, as well as the potential benefit of the surgical vs. pharmacologicaltreatment for this condition. For this purpose, a literature search for publications up to 2023 was carried out in PubMed, ScienceDirect, Web of Science and MEDLINE databases. It was shown that there is a significant risk of stroke associated with asymptomatic carotid stenosis (> 10 % approximately), even in patients with active antiplatelet and lipid-lowering therapy. Out of all those who receive medical treatment, around 80 % had a five-year survival rate. However, stenosisprogression occurs on average in more than 60 % of the cases and is significant. On the other hand, carotid stenting and endarterectomy are curative interventions. Nevertheless, these procedures involve a higher risk compared to the medicaltherapy during the peri- and postoperative period, as well as 30 days afterwards, due to the occurrence or recurrence of stroke, acute myocardial infarction or death from any cause. Despite this, the use of endarterectomy has shown superiorlong-term benefits concerning these same outcomes. Thus, evidence regarding the superiority of surgical treatment compared to pharmacological treatment for asymptomatic carotid atherosclerosis or stenosis is heterogeneous. However, it seems that surgical treatment, specifically endarterectomy, could have a significant impact on the occurrence orrecurrence of ipsilateral stroke and death in the long term but with controversial peri- and postoperative outcomes. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2023-09-13 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245 10.24265/horizmed.2023.v23n3.11 |
| url |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245 |
| identifier_str_mv |
10.24265/horizmed.2023.v23n3.11 |
| dc.language.none.fl_str_mv |
spa eng |
| language |
spa eng |
| dc.relation.none.fl_str_mv |
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1534 https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1574 https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1643 https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1658 https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1705 |
| dc.rights.none.fl_str_mv |
Derechos de autor 2023 Horizonte Médico (Lima) https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Derechos de autor 2023 Horizonte Médico (Lima) https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf text/xml text/html application/pdf text/xml |
| dc.publisher.none.fl_str_mv |
Universidad de San Martín de Porres. Facultad de Medicina Humana |
| publisher.none.fl_str_mv |
Universidad de San Martín de Porres. Facultad de Medicina Humana |
| dc.source.none.fl_str_mv |
Horizonte Médico (Lima); Vol. 23 No. 3 (2023): Julio-Setiembre; e2245 Horizonte Médico (Lima); Vol. 23 Núm. 3 (2023): Julio-Setiembre; e2245 Horizonte Médico (Lima); v. 23 n. 3 (2023): Julio-Setiembre; e2245 2227-3530 1727-558X reponame:Horizonte médico instname:Universidad de San Martín de Porres instacron:USMP |
| instname_str |
Universidad de San Martín de Porres |
| instacron_str |
USMP |
| institution |
USMP |
| reponame_str |
Horizonte médico |
| collection |
Horizonte médico |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1847257318138314752 |
| spelling |
Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?Riesgo de accidente cerebrovascular en pacientes con aterosclerosis carotídea asintomática: ¿se debe tratar médicamente o quirúrgicamente?Moreno Muñoz, Roberth Nixon Vergara Trujillo, Richard Adrián Guevara Lizarazo, German Andrés Brett Cano, Patrick Junior León Cuervo, Dalila Andrea Puerta Lidueñas, Adriana Marcela Sarmiento Figueroa, Mariana Ortega Sierra, Michaelstrokeriskcarotid artery diseasessurgical proceduresoperativetherapeutics accidente cerebrovascularriesgoenfermedades de las arterias carótidasprocedimientos quirúrgicos operativosterapéutica Cerebrovascular disorders remain the leading cause of neurological morbidity and mortality in the world, representing one of the pathological entities responsible for the greatest burden of disease worldwide. Carotid atherosclerosis or stenosis is a potential risk factor for ischemic stroke. The identification and strict follow-up of this condition are essential in the secondary prevention of complications through primary care and the specialized treatment of cardiometabolicrisk. However, depending on this risk and/or presence of symptoms, definitive treatment is necessary. Currently, there is controversy as to whether asymptomatic carotid stenosis is better to be treated medically or surgically. Consideringthe significance of such entity, this review aims to analyze recent evidence on the risk of ischemic stroke in the case of asymptomatic carotid atherosclerosis among adults, as well as the potential benefit of the surgical vs. pharmacologicaltreatment for this condition. For this purpose, a literature search for publications up to 2023 was carried out in PubMed, ScienceDirect, Web of Science and MEDLINE databases. It was shown that there is a significant risk of stroke associated with asymptomatic carotid stenosis (> 10 % approximately), even in patients with active antiplatelet and lipid-lowering therapy. Out of all those who receive medical treatment, around 80 % had a five-year survival rate. However, stenosisprogression occurs on average in more than 60 % of the cases and is significant. On the other hand, carotid stenting and endarterectomy are curative interventions. Nevertheless, these procedures involve a higher risk compared to the medicaltherapy during the peri- and postoperative period, as well as 30 days afterwards, due to the occurrence or recurrence of stroke, acute myocardial infarction or death from any cause. Despite this, the use of endarterectomy has shown superiorlong-term benefits concerning these same outcomes. Thus, evidence regarding the superiority of surgical treatment compared to pharmacological treatment for asymptomatic carotid atherosclerosis or stenosis is heterogeneous. However, it seems that surgical treatment, specifically endarterectomy, could have a significant impact on the occurrence orrecurrence of ipsilateral stroke and death in the long term but with controversial peri- and postoperative outcomes.Los desórdenes cerebrovasculares siguen siendo la primera causa de morbilidad y mortalidad neurológica en el mundo, representando una de las entidades patológicas que genera mayor carga de enfermedad a nivel global. La aterosclerosis, o estenosis carotídea, es un potencial factor de riesgo para el ictus isquémico. La identificación y seguimiento estricto de esta condición son esenciales en la prevención secundaria de complicaciones a través de la atención primaria y el manejo especializado del riesgo cardiometabólico. No obstante, dependiendo de este riesgo y/o la presencia de sintomatología, es necesario realizar un manejo definitivo. Actualmente, existe controversia sobre si es mejor tratar la estenosis carotídea asintomática, ya sea médica o quirúrgicamente. Teniendo en cuenta la relevancia de esta entidad, el objetivo de esta revisión consiste en analizar la evidencia reciente sobre el riesgo de ictus isquémico en la aterosclerosis carotídea asintomática en adultos, y el potencial beneficio del manejo quirúrgico vs. farmacológico de esta condición. Para esto, se llevó a cabo una búsqueda bibliográfica en las bases de datos PubMed, ScienceDirect, Web of Science y MEDLINE, hasta el año 2023. Se evidenció que el riesgo de ictus asociado a estenosis carotídea asintomática es significativo (>10 %, aproximadamente), incluso en aquellos con terapia antiplaquetaria e hipolipemiante activa. En aquellos con manejo médico, la supervivencia a cinco años es alrededor del 80 %. Sin embargo, la progresión de la estenosis sucede en promedio en más del 60 % de los casos, y es significativa. Por el contrario, el stent carotídeo y la endarterectomía son intervenciones resolutivas. Pero existe un riesgo mayor comparado con la terapia médica, el cual se atribuye al periodo peri- y posoperatorio, así como a 30 días de aparición o recurrencia del ictus, infarto agudo de miocardio o muerte por cualquier causa; aunque el uso de la endarterectomía ha demostrado beneficios superiores a largo plazo en cuanto a estos mismos desenlaces. Entonces, la evidencia es heterogénea en cuanto a la superioridad del tratamiento quirúrgico comparado con la terapia farmacológica en el manejo de la aterosclerosis o estenosis carotídea asintomática. Sin embargo, parece ser que el manejo quirúrgico, específicamente la endarterectomía, podría impactar significativamente sobre la aparición o recurrencia del ictus ipsilateral y muerte a largo plazo, pero con resultados controversiales peri- y postoperatorios. Universidad de San Martín de Porres. Facultad de Medicina Humana2023-09-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/xmltext/htmlapplication/pdftext/xmlhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/224510.24265/horizmed.2023.v23n3.11Horizonte Médico (Lima); Vol. 23 No. 3 (2023): Julio-Setiembre; e2245Horizonte Médico (Lima); Vol. 23 Núm. 3 (2023): Julio-Setiembre; e2245Horizonte Médico (Lima); v. 23 n. 3 (2023): Julio-Setiembre; e22452227-35301727-558Xreponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspaenghttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1534https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1574https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1643https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1658https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1705Derechos de autor 2023 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/22452023-09-13T16:00:13Z |
| score |
13.085615 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).